AXT Bring Novel Photoacoustic Imaging Technology to Australian Medical Researchers

AXT is pleased to announce a further expansion to their preclinical imaging portfolio with the addition of Luxonus who design and manufacture photoacoustic imaging systems.

Image credit: AXT

Their next-generation medical imaging technology generates much more data, in significantly greater detail, with less risk and less burden for patients and operators. These benefits come at lower cost than competitive technologies such as ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI).

Luxonus’ photoacoustic 3D imaging (PAI) provides super-high-resolution 3D imaging of blood vessels and lymph vessels safely and easily without using radiation exposure. Developed under the ImPACT program, a large national project, run by Japan’s Cabinet Office, to promote high-risk, high-impact R&D, this technology allows the accurate study of the morphology and function of blood vessels and lymphatic vessels. The resultant data enables a comprehensive understanding of the onset of disease, the healing process and the state of health before and after illness

[insert name and title] from Luxonus said of the new distribution agreement with AXT, “we are pleased to partner with AXT to bring our technology to Australia as we know they have a strong presence in the preclinical imaging sector and are well positioned to be able to grow our business in their region”.

In response, Richard Trett, Managing Director at AXT said, “we are excited to embrace another new technology that we know will help Australian researchers maintain their world-leading status in medical research, with the added benefit of opportunities to publish research using a new technology”.

For more details about the Luxonus 3D Photoacoustic Imager and AXT’s other complimentary preclinical image product lines, please visit https://www.axt.com.au/segments/biomedical-research-translational-research/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    AXT Pty Ltd. (2022, November 15). AXT Bring Novel Photoacoustic Imaging Technology to Australian Medical Researchers. AZoLifeSciences. Retrieved on November 29, 2022 from https://www.azolifesciences.com/news/20221115/AXT-Bring-Novel-Photoacoustic-Imaging-Technology-to-Australian-Medical-Researchers.aspx.

  • MLA

    AXT Pty Ltd. "AXT Bring Novel Photoacoustic Imaging Technology to Australian Medical Researchers". AZoLifeSciences. 29 November 2022. <https://www.azolifesciences.com/news/20221115/AXT-Bring-Novel-Photoacoustic-Imaging-Technology-to-Australian-Medical-Researchers.aspx>.

  • Chicago

    AXT Pty Ltd. "AXT Bring Novel Photoacoustic Imaging Technology to Australian Medical Researchers". AZoLifeSciences. https://www.azolifesciences.com/news/20221115/AXT-Bring-Novel-Photoacoustic-Imaging-Technology-to-Australian-Medical-Researchers.aspx. (accessed November 29, 2022).

  • Harvard

    AXT Pty Ltd. 2022. AXT Bring Novel Photoacoustic Imaging Technology to Australian Medical Researchers. AZoLifeSciences, viewed 29 November 2022, https://www.azolifesciences.com/news/20221115/AXT-Bring-Novel-Photoacoustic-Imaging-Technology-to-Australian-Medical-Researchers.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post